Elabscience® Launches First Magnetic Bead Product for Cell Selection
On September 22, 2026, Elabscience® Bionovation Inc. announced the launch of its latest product, the EasySort™ Mouse CD4 Nanobeads. This innovative magnetic bead product is specifically designed for the positive selection of CD4+ cells from mouse samples, marking a significant advancement in cell separation technology for researchers.
The EasySort™ Nanobeads feature dextran-coated superparamagnetic beads with particle sizes under 40 nanometers. These beads work in synergy with high-affinity antibodies developed by Elabscience®, ensuring the efficient enrichment of targeted cells while maintaining their integrity. Extensive internal validation has shown that the product achieves a remarkable cell purity level of 95.2% ± 3%, with a yield of 66% ± 18% and cell viability of at least 95%.
Overcoming Selection Challenges
Positive cell selection typically involves binding antibodies and magnetic beads to specific surface antigens on target cells. One of the primary challenges in this process is achieving high purity rates without negatively influencing the cell activation state or phenotype. The EasySort™ Mouse CD4 Nanobeads have been formulated to address these crucial aspects, allowing researchers to carry out downstream experiments without complications arising from altered cell states.
Dr. Yang Fei, the General Manager of Elabscience®, emphasized the necessity of high-quality cell separation, stating, "High-quality cell separation requires more than high target-cell purity. The separated cells must also retain the viability and phenotype needed for subsequent research." This is where the smaller superparamagnetic nanobeads shine, minimizing cell state disruption while enabling efficient enrichment of CD4+ cells.
Rigorous Testing and Validation
The development of EasySort™ Mouse CD4 Nanobeads is the result of a comprehensive R&D initiative that began in 2023. Elabscience®'s dedicated research team has meticulously optimized several processes, including nanobead preparation, antibody conjugation, magnetic labeling, and overall product formulation. Following thorough internal validation completed in July 2025, the product underwent additional multi-batch testing to ensure that it meets and exceeds industry standards. The results of these tests demonstrated that EasySort™ Nanobeads perform comparably to other commercial magnetic bead products currently available in the market.
Availability and Future Plans
The EasySort™ Mouse CD4 Nanobeads, identified by catalog number MIM011P, are now available in both 10- and 200-assay formats. The product can be utilized with a variety of mouse samples, including lymphoid tissues and internal organs such as the lungs. This launch represents the first step in a gradually expanding portfolio of positive cell selection magnetic bead products planned by Elabscience®. Future additions are anticipated as the company continues to innovate in cell separation technologies.
For the convenience of researchers, the EasySort™ Mouse CD4 Nanobeads can be ordered through Elabscience®'s network of local distributors worldwide or directly from their official website.
About Elabscience®
Founded in 2011, Elabscience® Bionovation Inc. is committed to delivering high-quality research reagents and services tailored for life sciences. With a broad array of products encompassing everything from protein detection to immunoassays and metabolism analysis, Elabscience® caters to the scientific community in over 150 countries. To learn more about their offerings, visit
www.elabscience.com and follow them on social media platforms for the latest updates.